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Background: Ambient air pollution has been associated with increased cardiovascular morbidity and mortality. In
Reykjavik, Iceland, air pollutant concentrations exceed official health limits several times every year. The aim was to
study the association of concentrations of NO2, O3, PM10, and H2S in the Reykjavik capital area with the dispensing
of anti-angina pectoris medication, glyceryl trinitrate to the inhabitants.
Methods: Data on daily dispensing of glyceryl trinitrate, were retrieved from the Icelandic Medicines Registry. Data
on hourly concentrations of NO2, O3, PM10, and H2S were obtained from the Environment Agency of Iceland. A
case-crossover design was used, based on the dispensing of glyceryl trinitrate to 5,246 individuals (≥18 years)
between 2005 and 2009.
Results: For every 10 μg/m3 increase of NO2 and O3 3-day mean concentrations, the odds ratio (OR) for daily
dispensing of glyceryl trinitrates was 1.136 (95% confidence intervals (CI) 1.069-1.207) and 1.094 (95% CI 1.029-1.163)
at lag 0, and OR was 1.096 (95% CI 1.029-1.168) and 1.094 (95% CI 1.028-1.166) at lag 1, respectively.
Conclusions: These findings suggest that NO2 and O3 ambient air concentrations may adversely affect
cardiovascular health, as measured by the dispensing of glyceryl trinitrates for angina pectoris. Further, the findings
suggest that data on the dispensing of medication may be a valuable health indicator when studying the effect of
air pollution on cardiovascular morbidity.
Keywords: Air pollution, Angina pectoris, Coronary disease, Case-crossover, Drug utilization, Nitrogen dioxide,
Ozone, PharmacoepidemiologyBackground
In previous studies an increased risk of cardiovascular
morbidity and mortality has been found in association
with exposure to air pollution [1-3]. In these studies dif-
ferent outcome measures were used such as hospital ad-
mission [4], emergency department visits [5], or deaths
[6,7] due to cardiovascular diseases. On the other hand,
some studies do not show an association between the
risk of cardiovascular morbidity and mortality and air
pollution [8,9].
Zeghnoun and coworkers [10] introduced the dispens-
ing of respiratory drugs as a novel indicator to measure* Correspondence: vilraf@hi.is
4Department of Preventive Medicine, University of Iceland, Reykjavík, Iceland
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© 2013 Finnbjornsdottir et al.; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumrespiratory morbidity in association with air pollution.
They implied that drug dispensing generally reflects less
severe morbidity states than those resulting in emer-
gency department visits, hospitalizations or death, and
could therefore serve as a sensitive marker to measure
the effects of air pollution in small populations where
mortality rates are low. Since then, only a few studies
have investigated the association of air pollution and the
dispensing of anti-asthma drugs as an indicator of re-
spiratory symptoms or asthma attacks [11-14].
To our knowledge, the dispensing of medication for
cardiovascular diseases has not previously been used to
estimate the possible effect of ambient air pollution on
cardiovascular health. In the following study, the aims
were to evaluate the association of changes in ambientCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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pensing of the sublingual medication glyceryl trinitrate
used against attacks of angina pectoris.
Methods
The study base consisted of inhabitants 18 years or older
in the Reykjavik capital area (communities: Reykjavik,
Seltjarnarnes, Kopavogur, Hafnarfjordur, Gardabaer, and
Mosfellsbaer) identified by postal codes (Figure 1).
According to Statistics Iceland the annual mean population
was 142,789 individuals (≥18 years) [15]. The study period
was January 1, 2005 to December 31, 2009.
Exposure and covariate assessment
The Environment Agency of Iceland provided the expos-
ure data. The agency continuously measures air pollu-
tion levels of various pollutants at a busy intersection of
two main roads in Reykjavik (Grensasvegur-Miklabraut)
where on average around 60,000 cars cross daily
(Figure 1) [16]. In this study, 1-hour measurements
were obtained for NO2, O3, PM10, and H2S concentrations.
Gaps in exposure measurements were due to occasionally
inactive measuring equipment. PM10 was measured with
an Andersen EMS IR Thermo (model FH62 I – R, Thermo
Scientific, United States) and NO2, H2S, and O3 with a
Horiba (models APNA 360E, APSA 360ACE, and APOA
360E, Horiba, United States). These devices are calibrated
every six to twelve months.Figure 1 Map of the location of NO2, O3, PM10, and H2S measurem
Grensasvegur-Miklabraut intersection in the Reykjavik capital area of Icelan
indicate point sources of H2S emissions, the Hellisheidarvirkjun and NesjavThe entire dataset contained 1,826 days (5 years). The
24-hour mean concentration values (from the time 00:00
to 00:00 the following day) were calculated for each pol-
lutant, using the 1-hour values where at least 75% of the
data existed. The number of days in which the 75% cri-
terion was fulfilled varied by pollutant; missing 24-hour
values were 143 (8%) for NO2, 83 (4%) for O3, and 36
(2%) for PM10. H2S measurements started on February
22, 2006 and therefore do not provide complete data.
H2S measurements thus contribute 1,409 days to the
dataset, for which 219 days (15%) were missing. The
NO2, O3, and PM10 are traffic related, however deserts
dust and volcanic ashes contribute to the concentration
of PM10 in the Reykjavik area depending on wind direc-
tion. The source of H2S is two geothermal power plants
26 and 33 km east of the city. For meteorological data,
24-hour mean values were retrieved from the same
measurement location as for the pollutants. Missing days
were 13 (<1%) for temperature and relative humidity
(RH). Missing values were not associated with any par-
ticular day in the week. The 3-day means were calcu-
lated for each pollutant and meteorological data based
on 24-hour values, giving the running averages of the
day when dispensing occurred (index day), one day be-
fore and two days before the index day, so the 3-day
means included the day of dispensing.
Monthly numbers of influenza cases were obtained
from the Directorate of Health and were recalculatedent device (GRE). The measurement location is by the
d. Dotted line indicates the boundary of the capital area and circles
allavirkjun power plants.
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month to define an influenza season.
Case ascertainment
The Icelandic Medicines Registry was the source of
the outcome data and the registry contains informa-
tion for each person to whom prescription medica-
tion was dispensed as an outpatient during the study
period. The coverage of the database is virtually
complete in the Reykjavik area for all filled prescrip-
tions in outpatient settings [17]. For each occurrence
of glyceryl trinitrate dispensing in the study we re-
ceived information on medication name, number of
defined daily doses (DDDs), Anatomic Therapeutic
Chemical (ATC) code [18], dispensing date, encrypted
personal identification number, sex, birth year, and
residential postal code of the patient. The personal
identification number allowed checking whether drug
dispensing had occurred with seven days intervals, to
avoid overlap with control days.
We retrieved information on all filled prescriptions
defined as glyceryl trinitrates (ATC code: C01DA02),
the target medication in this study. Glyceryl trinitrates
are used against an abrupt onset of painful attacks of
angina pectoris. An effective dose of glyceryl trinitrate
administered sublingually acts within minutes, usually
terminating pain quickly and completely, making it an
ideal medication to study in association with air pol-
lution fluctuations. No information on underlying
medical conditions was available from the IcelandicTable 1 Air pollution statistics
Days, n Mean (SD) Min Max Pearso
PM10
24-hour mean
PM10, μg/m3 1,790 22.6 (20.8) 3.2 261.6 1
NO2, μg/m3 1,683 20.8 (13.5) 0.7 100.6 0.13
O3, μg/m3 1,744 40.7 (13.8) 1.2 144.5 0.13
H2S, μg/m3 1,190 3.8 (6.7) 0.0 92.5 0.02
Rel. humidity, % 1,813 77.8 (10.9) 39.3 102.5 a −0.33
Temperature, °C 1,813 5.9 (5.2) −10.3 22.2 −0.28
3-day mean PM10
PM10, μg/m3 1,811 20.5 (15.3) 4.6 125.7 1
NO2, μg/m3 1,707 20.7 (10.9) 0.7 100.6 0.11
O3, μg/m3 1,765 40.8 (11.5) 5.8 108.9 0.22
H2S, μg/m3 1,282 3.8 (5.1) 0.1 69.5 −0.01
Rel. humidity, % 1,824 77.8 (9.1) 43.0 101.2a −0.34
Temperature, °C 1,824 5.9 (5.0) −7.3 18.2 −0.43
Abbreviations: H2S: hydrogen sulfide; Max: maximum value over specific time period; M
period; NO2: nitrogen dioxide; O3: ozone; PM10: particulate matter with an aerodynamic
a The maximum value of relative humidity is 100%. There is a 2.5% error margin in
Description of air pollution in Reykjavik, Iceland, over the study period of January 1
are shown as well as Pearson’s correlation coefficient between pollutant factors.Medicines Registry. Other drugs used against angina
pectoris were not taken into consideration in this
study. These are long acting nitrates, beta blockers,
and calcium channel blockers and when used against
angina pectoris these medicines should be taken regu-
larly. Beta blockers and calcium channel blockers are
indicated for several other medical conditions than
angina pectoris. The glyceryl trinitrate is the only
medicine against angina pectoris used intermittently
when the patient has an attack of chest pain. In the
study all drug dispensing was according to prescrip-
tion and it was not possible to differ between new
prescription and renewal fills due to routine or ex-
acerbation of symptoms. Some patients may have had
prescription valid for up to four repeated fillings, and
recognition of these prescriptions was not possible. A
package of glyceryl trinitrate, which has been opened
expires in eight weeks.
Three preconditions were needed to be defined as a
case; 1) the individual was living in the Reykjavik capital
area, 2) the individual was 18 years or older, and 3) gly-
ceryl trinitrates were dispensed to the individual at least
once over the study period. The total number of cases
over the study period was 5,246.Design and data analysis
Pearson’s correlation was used to assess the inter-
correlation between exposure factors and the meteoro-
logical covariates (Table 1).n's correlation coefficient




0.04 −0.07 0.03 1
−0.43 −0.04 −0.28 0.15 1




0.03 −0.07 0.05 1
−0.48 −0.12 −0.34 0.14 1
ean: mean value over specified time period; Min: minimum value over specific time
diameter of ≤10 μm; Rel. humidity: relative humidity; SD: standard deviation.
the measuring equipment.
st 2005 to December 31st 2009. 24-hour mean values and 3-day mean values
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studying the association of transient exposure, such as
air pollution, and an acute onset event, such as the dis-
pensing of anti-angina pectoris medication, glyceryl tri-
nitrate [19]. The symmetric bidirectional design with
selection of two controls, seven days before and after the
index day (day of dispensing glyceryl trinitrate) was used
[20]. The case-crossover design compares each person’s
exposure experience in a time period just prior to the
case-defining event with that same person’s exposure ex-
perience seven days before and seven days after the
event. This matches controls for measured or unmeas-
ured personal confounding characteristics that do not
vary over the relatively short time, such as gender, age,
and genetic factors [20].
We conducted several calculations including single
pollutants NO2, O3, PM10, H2S, temperature, humidity,
and influenza seasons to each single pollutant model.
Two separate multi pollutant models were used, one
introducing three pollutants, NO2, O3, and PM10, based
on 24-hour means of the pollutants, and another intro-
ducing four pollutants, NO2, O3, PM10, and H2S both
adjusted for temperature and humidity on the same day.
Finally, all models were also run with pollutant exposure
averaged over three consecutive days (3-day means), also
adjusted for temperature and humidity. These models
were also run with and without adjustment for the influ-
enza periods.
A lag time up to three days was introduced in the ana-
lyses according to the following definitions: lag 0: air pol-
lution exposure on the dispensing day, lag 1-3: air
pollution exposure one day before (lag 1) and up to three
days before (lag 3) the dispensing day. We obtained esti-
mates of odds ratios (OR) for the association of each pol-
lutant, using conditional logistic regression. Sets were
excluded if there were two or more missing values in the
matched case control set (a complete set contains three
exposure values). We reported effects estimates as the
change in dispensing of glyceryl trinitrate associated with
10 μg/m3 increase in 24-hour mean or 3-day mean pollu-
tant levels.
A few conditional logistic regression calculations with
different controls in the symmetric bidirectional case-
crossover design were conducted. Firstly, both days of
the bidirectional controls were used, i.e., the same day of
the week one week before and one week after the index
day; secondly, one control day was used, the same day of
the week one week before the index day; thirdly, one
control day was used, the same day of the week one
week after the index day; and fourthly, one control day
was randomly chosen from the same day of the week ei-
ther a week before or a week after the index day. This
fourth procedure is called semisymmetric bidirectional
control selection [20]. If only one of these days wasavailable, as a result of the case being at either the end
of the exposure series, that day served as the sole con-
trol day. Overlap bias is avoided by the semisymmetric
bidirectional design [20]. All these calculations gave
nearly identical results and therefore the only results
based on the symmetric bidirectional controls are shown
in this presentation.
We used SPSS 16.0 (IBM software, United States) and
STATA 11 (StataCorp, United States) for all analyses.
The study protocol was approved by the National Bio-
ethics Committee (ref. no. VSNb2010030008/03.7) and




Excluding repeated dispensing occurrences to the same
patient on the same day, glyceryl trinitrates were dis-
pensed 8,604 times to a total of 5,246 individuals (57.9%
males, 40.1% females) over the study period. On average,
dispensing of glyceryl trinitrate occurred 4-5 times each
day to the patients in the study base, range 0 to 19 per
day. The mean age of the patients was 74 years (median
76 years, interquartile range 67, 82 years). Around 98%
of individuals who used glyceryl trinitrates filled fewer
than five prescriptions per year, and approximately 73%
filled one prescription per year. The majority of dispens-
ing occurrences took place on weekdays rather than on
weekends or holidays.
NO2 and O3 followed a seasonal pattern with higher
concentrations during winter, whereas such a pattern was
not as clear for PM10 and H2S (Figure 2). The 24-hour
mean during winter months (November 1 to April 30)
was 25 μg/m3 (standard deviation (SD) 15) and 43 μg/m3
(SD 15) for NO2 and O3, respectively. Over the summer
months (May 1 to October 31) the 24-hour mean was
16 μg/m3 (SD 15) and 38 μg/m3 (SD 12) for the same
pollutants. The inter-correlation was strongest between
24-hour mean concentration levels of NO2 and O3 where
there was a negative correlation of -0.62 (Table 1), while
the strongest positive correlation of 0.41 was between the
3-day means of NO2 and H2S. Temperature was negatively
correlated with each pollutant and relative humidity corre-
lated negatively with PM10 and O3 (Table 1).
Air pollution and glyceryl trinitrate dispensing
The matched OR and 95% CI for the dispensing of gly-
ceryl trinitrate associated with every 10 μg/m3 increase
in NO2, O3, PM10, and H2S 24-hour mean, as well as
temperature, humidity, and influenza season in single pol-
lutant model, applying lag 0 and 1 can be seen in Table 2.
A significant association was found between the dispensing
of glyceryl trinitrate and the 24-hour mean concentrations
of NO2 with lag 0. Due to the low correlation between
Figure 2 (See legend on next page.)
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Figure 2 Time-series plot of air pollutants and glyceryl trinitrate drug dispensing. 3-day mean concentration of pollutants (μg/m3) and daily
number of glyceryl trinitrate drug dispensing in Reykjavik, Iceland over the study period of January 1, 2005 to December 31, 2009. Measurements
of H2S started in February 2006. Gaps in figures are due to missing data.
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measured pollutants, a multipollutant model was also ap-
plied (Table 3). A significant positive association was
found between the dispensing of glyceryl trinitrate and
the 24-hour mean concentrations of NO2 and O3. At lag
0 and 1 a significant odds ratio (OR) of 1.059 (95% CI:
1.012, 1.108) and 1.074 (95% CI: 1.025, 1.126) for NO2
was evident. For O3, there was a significant OR of 1.087
(95% CI: 1.035, 1.141) at lag 1. The multi-pollutant model
was run with and without H2S and when introducing H2S
in the model, the pattern of the association of the other ex-
posure factors did not change. The 95% CI of the ORs for
24-hour mean concentrations of H2S and PM10 include
unity at every time lag and are therefore not statistically
significant (Table 3).
The 3-day mean concentration values yielded a stron-
ger association than the 24-hour mean concentration
values. At lag 0 the OR was 1.136 (95% CI: 1.069, 1.207)
and 1.094 (95% CI: 1.029, 1.163) in daily occurrences of
glyceryl trinitrate dispensing following an increase in the
3-day mean concentrations of NO2 and O3, respectively.
At lag 1, the increase in occurrences of glyceryl trinitrate
dispensing was 1.096 for NO2 (95% CI: 1.029, 1.168) and
1.094 for O3 (95% CI: 1.028, 1.166). The OR at lag 2 and
3 was not statistically significant for either pollutant
(Table 3 and Figure 3). H2S showed a different pattern
compared with NO2 and O3, where lag 0 and lag 1
showed a decrease (lag 0: 0.934; 95% CI: 0.866, 1.008
and lag 1: 0.975; 95% CI: 0.906, 1.048). At lag 2 and lag
3 there was an increase of 1.003 (95% CI: 0.933, 1.079)
and 1.027 (95% CI: 0.951, 1.109), respectively. ORs for
H2S were not statistically significant at any time lag.
PM10 also had a different pattern than the other pollut-
ants where the OR was around 1 at every time lag and
therefore not statistically significant at any time lag
(Table 3 and Figure 3).Table 2 Association of 24-hour air pollutant concentrations an
NO2 O3
Lag OR 95% CI OR 95% CI
0 1.038 1.011, 1.062 0.988 0.965, 1.012
1 1.015 0.991, 1.040 1.017 0.993, 1.041
Temperature Relative humidity
Lag OR 95% CI OR 95% CI
0 1.019 0.936, 1.111 1.020 0.994, 1.046
1 0.986 0.904, 1.074 1.001 0.976, 1.027
The matched odds ratios (OR) and 95% confidence intervals (CI) for the dispensatio
increase in NO2, O3, PM10, H2S, temperature, and relative humidity 24-hour mean coIntroducing the influenza season to the models did
not change the pattern of ORs for these exposures, as
the ORs became only slightly elevated when the influ-
enza season was included. The OR for influenza season
was in no instance statistically significant as a con-
founder on a 5% level, except in the model when H2S
was not included and at lag 0.
Discussion
In this study we found that exposure to urban air pol-
lution was associated with the dispensing of glyceryl
trinitrates (ATC code: C01DA02) among adults living
in the Reykjavik area. The results show an increase of
13.6% and 9.6% in occurrences of glyceryl trinitrate
dispensing for every 10 μg/m3 increase in the 3-day
mean of NO2 at lag 0 and lag 1. Likewise, an increase
of 9.4% and 9.4% in glyceryl trinitrate dispensing for
every 10 μg/m3 increase the 3-day mean of O3 at lag
0 and lag 1 was evident.
Air pollution is believed to affect the biological path-
way of the cardiovascular mechanism [21-23] but in
what way is not yet clear. An experimental study on
humans indicated that inhalation of fine particulate air
pollution and ozone may cause acute arterial vasocon-
striction that could lead to cardiovascular events [24]. A
similar study showed that air pollution impairs endothe-
lial function in young healthy males [25].
This study found an increase in dispensing of glyceryl
trinitrate on the same day as increases NO2 and O3 oc-
curred (lag 0). When an increase in NO2 and O3 oc-
curred the day before (lag 1), there was also an increase
in glyceryl trinitrate dispensing. This is evident for both
24-hour mean and 3-day mean concentrations. One of
the major conditions for concluding on causality, that
the exposure precedes the outcome, is fulfilled in the
present study [26]. The 3-day mean of NO2 and O3 thatd glyceryl trinitrate dispensing in a single pollutant model
PM10 H2S
OR 95% CI OR 95% CI
1.005 0.929, 1.017 0.997 0.991, 1.004





n of glyceryl trinitrate in Reykjavik, Iceland, associated with every 10 μg/m3
ncentrations, and influenza seasons.
Table 3 Association of air pollutants and glyceryl trinitrate dispensing in a multi-pollutant model
NO2 O3 PM10 H2S
Lag OR 95% CI OR 95% CI OR 95% CI OR 95% CI
24-hour mean
Model not including H2S
0 1.069 1.028, 1.112 1.036 0.995, 1.078 1.005 0.991, 1.018
1 1.081 1.038, 1.125 1.088 1.045, 1.133 0.999 0.985, 1.014
2 1.037 0.994, 1.083 1.036 0.995, 1.080 1.003 0.988, 1.019
3 1.027 0.983, 1.074 1.020 0.978, 1.064 0.988 0.971, 1.004
Model including H2S
0 1.059 1.012, 1.108 1.015 0.968, 1.065 1.002 0.985, 1.020 0.987 0.933, 1.045
1 1.074 1.025, 1.126 1.087 1.035, 1.141 0.995 0.976, 1.013 0.958 0.907, 1.013
2 1.054 1.003, 1.108 1.047 0.996, 1.101 1.001 0.982, 1.020 0.972 0.922, 1.025
3 1.032 0.980, 1.087 1.028 0.976, 1.083 0.983 0.962, 1.004 1.030 0.979, 1.083
3 day mean
Model not including H2S
0 1.116 1.059, 1.176 1.090 1.036, 1.146 1.009 0.988, 1.030
1 1.071 1.014, 1.130 1.072 1.019, 1.129 0.998 0.976, 1.021
2 1.013 0.957, 1.071 1.018 0.965, 1.073 0.996 0.973, 1.019
3 0.977 0.923, 1.034 0.990 0.938, 1.046 1.000 0.978, 1.022
Model including H2S
0 1.136 1.069, 1.207 1.094 1.029, 1.163 0.998 0.972, 1.024 0.934 0.866, 1.008
1 1.096 1.029, 1.168 1.094 1.028, 1.166 0.988 0.961, 1.015 0.975 0.906, 1.048
2 1.045 0.978, 1.117 1.038 0.972, 1.108 0.983 0.956, 1.012 1.003 0.933, 1.079
3 0.993 0.929, 1.061 0.997 0.933, 1.065 0.985 0.958, 1.013 1.027 0.951, 1.109
Data have been calculated in a unique multivariate analysis separately for each lag, taking into account simultaneously each pollutant variables.
No. of observations for 24-hour mean not including H2S: lag 0: 22,436; lag 1: 22,327; lag 2: 22,288; and lag 3:22,367. No. of observations for 24-hour mean
including H2S: lag 0: 13,816; lag 1: 13,686; lag 2: 13,598; and lag 3: 13,650. No. of observations for 3-day mean not including H2S: lag 0: 21,913; lag 1: 21,755; lag 2:
21,617; and lag 3: 21,682. No. of observations for 3-day mean including H2S: lag 0: 13,816; lag 1: 13,686; lag 2: 13,598; and lag 3: 13,650.
The matched odds ratios (OR) and 95% confidence intervals (CI) for the dispensation of glyceryl trinitrate in Reykjavik, Iceland, associated with every 10 μg/m3
increase in NO2, O3, PM10, and H2S 24-hour mean and 3-day mean concentrations. Adjusted for each pollutant variable, temperature, and relative humidity.
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than the 24-hour mean concentrations, and thus a stron-
ger association with the dispensing of glyceryl trinitrate.
Using the 3-day mean eliminates the possibility that
the dispensing occurs before the exposure, whereas when
using the 24-hour mean, the dispensing could theoretic-
ally occur during the exposure, as the 3-day mean yielded
higher OR than the 24-hour mean. We also found a
strong statistically significant increase in dispensing of
glyceryl trinitrate at lag 1 for NO2 and O3, suggesting
that patients use more glyceryl trinitrates when increases
in the 3-day mean occur one day before the index day.
Concurrent with our results, Bhaskaran and coworkers
[27] found that 10 μg/m3 increases in NO2 levels were
associated with a 1.1% increased risk of myocardial in-
farction (MI) only 1-6 hours after the exposure occurred,
a time frame that would have fallen within lag 0 in our
study. However, we did not find an association between
PM10 and glyceryl trinitrate dispensing, while Bhaskaran
and coworkers demonstrated a 1.2% increase of MI withevery 10 μg/m3 increase in PM10 [27]. Moreover, the
Bhaskaran study is inconsistent with our results, in that
they found no association between O3 and MI. Quite a
few studies have demonstrated elevated relative risks,
measured as MI [28,29], hospital admissions [30], and
emergency department visits [31] due to cardiovascular
diseases, on the same day and one day after increases in
NO2 and O3 concentration occur (lag 0 and 1) [28,30].
Notably, von Klot and coworkers found a 1.32% increase
in readmissions due to angina pectoris, the condition
for which glyceryl trinitrates is prescribed, following
an 8 μg/m3 increase in NO2 concentrations [30].
PM10 was not associated with glyceryl trinitrate dis-
pensing at any lag in our study. Previous case-crossover
studies have demonstrated an association of PM10 and
PM2.5 with cardiovascular morbidity [4,29,32]. Some
other studies have failed to find a statistically significant
association of PM and cardiovascular morbidity [8,9].
Our findings concerning PM10 may be due to the rela-
tively low PM10 levels in the Reykjavik area. Long-term
Figure 3 Association of NO2, O3, PM10, and H2S exposure (3-day mean) and daily glyceryl trinitrate dispensing. Figure shows up to lag
0-3 days, adjusted for each pollutant variable, temperature, and relative humidity. Bars show 95% confidence intervals (CI).
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affect cardiovascular health. Still, the potential adverse
effect of coarse particles (PM2.5-10) should not be ig-
nored. Unfortunately, we did not have access to PM2.5
measures and no information on the proportion of parti-
cles smaller than 2.5 μm in aerodynamic diameter within
the PM10 concentrations was available.
We did not find any statistically significant associa-
tions of increases in H2S concentrations and glyceryl
trinitrate dispensing at any time lag. However, introdu-
cing H2S into the 3-day mean analysis yielded the
highest OR for NO2 and O3 at lag 0 and lag 1. So, H2S
did not seem to be an independent risk factor for glyceryl
trinitrate dispensing. The possible effect of H2S on car-
diovascular morbidity has not been as intensively studied
as NO2, PM10, and O3. Iceland offers a rare setting to
study the association of H2S and morbidity and mortality
based on the availability of detailed H2S measurements
and population-based registries including individual
health information. The source of H2S in Reykjavik is
two geothermal power plants, Hellisheidarvirkjun and
Nesjavallavirkjun, located 26 and 33 km east of the city,
while the other pollutants in this study are mostly traffic-
related. The few existing studies on H2S using mortality
and hospital discharge as outcome measures suggest that
long-term exposure to moderately high concentrations of
H2S is associated with cardiovascular- and respiratory
morbidity [33,34]. In Reykjavik, the intermittent concen-
trations of H2S are not likely to be evenly dispersed over
the city, and therefore, these findings call for further ana-
lysis of the potential adverse health effects of H2S.An imperative strength of this case-crossover study is
the design that adjusts for seasonality, time trends, and
slowly time-varying confounders, since the control expo-
sures are within the same season and day of the week as
the case exposure. The model makes within-subject com-
parisons possible and time-independent confounders are
controlled for by design. Therefore, individual character-
istic adjustments are not needed. In our assessments we
controlled for temperature, relative humidity, and influ-
enza season. Further, we tested whether different control
samplings affected our results. This was not the case, as
the pattern of associations between air pollutants and
glyceryl trinitrate dispensing remained similar and statis-
tically significant. Moreover, the Icelandic Medicines
Registry is virtually complete, since all filled prescriptions
in outpatient settings are registered according to per-
sonal identification numbers. Such completeness of a
medication registry is quite unique. Finally, glyceryl
trinitrates are not prescribed unless the patient has an-
gina pectoris and therefore there is no incidence of dis-
pensing the medication to individuals who do not suffer
from cardiovascular disease.
The study has limitations that should be mentioned.
Firstly, the data did not allow an identification of
whether individuals to whom glyceryl trinitrates was dis-
pensed were previously known to have angina pectoris,
or if they were newly diagnosed with angina pectoris at
the time of dispensing. Some patients with angina
pectoris may of course have had glyceryl trinitrates at
hand, ready to use in case of exacerbation, and thus do
not need a new dispensation at the time of exacerbation,
Finnbjornsdottir et al. Environmental Health 2013, 12:38 Page 9 of 10
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tion. Such course of events would diminish the possibil-
ity to find an association between drug dispensing and
an increase in pollution concentrations with a short lag.
Secondly, the air pollution data were only derived from
one monitoring station. The study therefore has the in-
herent weakness that the exposure concentrations were
not on an individual basis, but cover the whole popula-
tion of the Reykjavik area with one station as a proxy for
exposure. This monitoring station was the only one
available in the Reykjavik area during the study period.
Conclusions
To our knowledge, this is the first study where the dis-
pensing of glyceryl trinitrates is used as a public health
indicator in relation to ambient air pollution. Our results
suggest that NO2 and O3 ambient air concentrations
may adversely affect cardiovascular health, as measured
by the dispensing of the anti-angina pectoris medication,
glyceryl trinitrates.
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